Biotech Analysts That Do Well Have a Hybrid Research/Banker Role
Technically speaking this shouldn’t be allowed…. But from every biotech analyst I know their day-to-day is honestly more banker type and that’s why they get paid so much. When you think about the significant amount of raising biotechs do, it makes sense.
Just an observation - I think bio SS can in many ways be a better seat than buyside if you have a path to Analyst at your shop. Thinking risk/reward here
Source? Can you elaborate?
Minima quis est fugiat molestiae. Facere qui eum sunt voluptatem id sunt quisquam dolore. Officiis repellat est illo. Est error voluptatum est consequuntur voluptatem et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...